VOYA Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-31,013
Closed -$124K 2705
2019
Q4
$124K Buy
31,013
+7,372
+31% +$34.6K ﹤0.01% 2501
2019
Q3
$116K Hold
23,641
﹤0.01% 2376
2019
Q2
$144K Hold
23,641
﹤0.01% 2382
2019
Q1
$137K Hold
23,641
﹤0.01% 2363
2018
Q4
$318K Buy
23,641
+1,469
+7% +$24.8K ﹤0.01% 1990
2018
Q3
$430K Hold
22,172
﹤0.01% 1942
2018
Q2
$567K Buy
22,172
+531
+2% +$12.4K ﹤0.01% 1739
2018
Q1
$436K Hold
21,641
﹤0.01% 1887
2017
Q4
$434K Hold
21,641
﹤0.01% 1928
2017
Q3
$448K Hold
21,641
﹤0.01% 1934
2017
Q2
$320K Buy
21,641
+2,040
+10% +$34K ﹤0.01% 2119
2017
Q1
$313K Hold
19,601
﹤0.01% 2020
2016
Q4
$247K Hold
19,601
﹤0.01% 2175
2016
Q3
$549 Hold
19,601
﹤0.01% 1671
2016
Q2
$686K Buy
19,601
+4,006
+26% +$126K ﹤0.01% 1495
2016
Q1
$427K Hold
15,595
﹤0.01% 1790
2015
Q4
$534K Hold
15,595
﹤0.01% 1672
2015
Q3
$448K Sell
15,595
-1,839
-11% -$78.6K ﹤0.01% 1787
2015
Q2
$780K Buy
17,434
+8,991
+106% +$338K ﹤0.01% 1616
2015
Q1
$292K Hold
8,443
﹤0.01% 2238
2014
Q4
$231K Buy
+8,443
New +$205K ﹤0.01% 2410

Other funds holding DPLO

VOYA Investment Management's DPLO Position: Q1 2020 in Review

VOYA Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 31,013 shares — an estimated $124K sold.

VOYA Investment Management first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $780K in Q2 2015. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • VOYA Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • VOYA Investment Management sold 31,013 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $124K.
  • VOYA Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
  • VOYA Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $780K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on VOYA Investment Management's 13F filing for Q1 2020, filed 15 May 2020.